Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-12-02 00:00:00 ET · period of report 2025-11-28 · accession 0001193125-25-305662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 2025-11-28 | SRPT | Rothfuss Cristin | EVP, GC | F - Tax | $21.12 | -229 | 139.8K | -0.2% | -$4,836 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | F | D | 229 | $21.12 | 139,756 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 26, 2024. |